psychiatryRounds

Connecting Psychiatry - Expert community for all mental health professionals

(PSYCHIATRIC TIMES) - MADRID, July 20 -- An investigational transdermal patch to deliver an Alzheimer's drug appears to be as effective as currently marketed Exelon (rivastigmine) capsules and eases compliance worries, researchers said here.

"The rivastigmine patch provides similar efficacy to the highest capsule doses, and was superior to placebo," said Bengt Winblad, MD, of Karolinska Institute in Stockholm reported at the at the International Conference on Alzheimer's Disease and Related Disorders here.

For full article, please visit:
http://www.psychiatrictimes.com/alzheimer-dementia/article/10162/14494

Views: 3

Comment

You need to be a member of psychiatryRounds to add comments!

Join psychiatryRounds


psychiatryRounds Social Media

Sponsors

CMEinfo: Board Reviews in Anesthesia, Cardiology, Internal Medicine, Radiology

© 2019   Created by PsychiatryRounds Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service